GlassScriptPhysician profile
Vivian Blanco
NPI 1871165852
$7,106.45
in general payments reported to CMS, 2019-2025
17 companies · $2,825 in 2025
The $2,825 reported for 2025 was more than what 96% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $431 · 2022: $1,053 · 2023: $968 · 2024: $1,830 · 2025: $2,825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,623.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,622.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $1,247.88 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $1,071.11 | 2021-2025 | Rexulti, Nuedexta, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $1,046.17 | 2021-2025 | Spravato, Invega Sustenna |
| Abbvie INC. | $727.89 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $587.34 | 2023-2025 | Ingrezza |
| Axsome Therapeutics, INC. | $480.38 | 2023-2025 | Auvelity |
| Alkermes, INC. | $457.07 | 2025 | Lybalvi, Aristada |
| Teva Pharmaceuticals USA, INC. | $420.67 | 2024-2025 | Uzedy, Austedo Xr |
| Novo Nordisk INC | $239.20 | 2025 | Wegovy |
| E.R. Squibb & Sons, L.L.C. | $210.70 | 2024-2025 | Cobenfy |
| Corium, LLC | $163.54 | 2022-2024 | Azstarys |
| Vanda Pharmaceuticals INC. | $135.24 | 2025 | Fanapt |
| Lundbeck LLC | $114.59 | 2023-2025 | Rexulti |
| Eisai INC. | $98.48 | 2021 | |
| Collegium Pharmaceutical, INC. | $48.85 | 2025 | Jornay Pm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $39.34 | 2023-2024 | Trintellix |
| Biogen, INC. | $18.00 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivian Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.